199 related articles for article (PubMed ID: 8772594)
1. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).
Caron P; Gerbeau C; Pradayrol L; Simonetta C; Bayard F
J Clin Endocrinol Metab; 1996 Mar; 81(3):1164-8. PubMed ID: 8772594
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P
J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
[TBL] [Abstract][Full Text] [Related]
3. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M
Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085
[TBL] [Abstract][Full Text] [Related]
4. Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.
Gruszka A; Zielinski GM; Kunert-Radek J
J Clin Neurosci; 2014 Feb; 21(2):340-2. PubMed ID: 23958483
[TBL] [Abstract][Full Text] [Related]
5. Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).
Sy RA; Bernstein R; Chynn KY; Kourides IA
J Clin Endocrinol Metab; 1992 Mar; 74(3):690-4. PubMed ID: 1740506
[TBL] [Abstract][Full Text] [Related]
6. TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide.
Fischler MP; Reinhart WH
J Endocrinol Invest; 1999 Jan; 22(1):64-5. PubMed ID: 10090139
[TBL] [Abstract][Full Text] [Related]
7. Octreotide changes serum thyrotropin (TSH) glycoisomer distribution as assessed by lectin chromatography in a TSH macroadenoma patient.
Francis TB; Smallridge RC; Kane J; Magner JA
J Clin Endocrinol Metab; 1993 Jul; 77(1):183-7. PubMed ID: 8325941
[TBL] [Abstract][Full Text] [Related]
8. Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy.
Caron P; Buscail L; Beckers A; Estève JP; Igout A; Hennen G; Susini C
J Clin Endocrinol Metab; 1997 Nov; 82(11):3771-6. PubMed ID: 9360539
[TBL] [Abstract][Full Text] [Related]
9. Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection.
Mozas J; Ocón E; López de la Torre M; Suárez AM; Miranda JA; Herruzo AJ
Int J Gynaecol Obstet; 1999 Apr; 65(1):71-3. PubMed ID: 10390105
[TBL] [Abstract][Full Text] [Related]
10. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy.
Blackhurst G; Strachan MW; Collie D; Gregor A; Statham PF; Seckl JE
Clin Endocrinol (Oxf); 2002 Sep; 57(3):401-4. PubMed ID: 12201834
[TBL] [Abstract][Full Text] [Related]
11. Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: a therapeutic challenge.
Nguyen HD; Galitz MS; Mai VQ; Clyde PW; Glister BC; Shakir MK
Thyroid; 2010 Jan; 20(1):99-103. PubMed ID: 20067380
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic thyrotropin-secreting pituitary macroadenoma in a 13-year-old girl: successful first-line treatment with somatostatin analogs.
Rabbiosi S; Peroni E; Tronconi GM; Chiumello G; Losa M; Weber G
Thyroid; 2012 Oct; 22(10):1076-9. PubMed ID: 22947349
[TBL] [Abstract][Full Text] [Related]
13. [Octreotide in the diagnosis and treatment of pituitary thyrotropin-secreting adenoma].
Chen S; Li M; Lian XL; Zeng ZP; Dai WX; Li F; Yu W; Wang RZ
Zhonghua Nei Ke Za Zhi; 2006 Nov; 45(11):910-3. PubMed ID: 17313878
[TBL] [Abstract][Full Text] [Related]
14. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
[TBL] [Abstract][Full Text] [Related]
15. Management of a pregnant woman with thyrotropinoma: a case report and review of the literature.
Perdomo CM; Árabe JA; Idoate MÁ; Galofré JC
Gynecol Endocrinol; 2017 Mar; 33(3):188-192. PubMed ID: 27910710
[TBL] [Abstract][Full Text] [Related]
16. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
Iglesias P; Díez JJ
J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
[TBL] [Abstract][Full Text] [Related]
17. Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma.
Wémeau JL; Dewailly D; Leroy R; D'Herbomez M; Mazzuca M; Decoulx M; Jaquet P
J Clin Endocrinol Metab; 1988 Mar; 66(3):636-9. PubMed ID: 2895119
[TBL] [Abstract][Full Text] [Related]
18. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
Hubalewska-Hola A; Fröss K; Kostecka-Matyja M; Sowa-Staszczak A; Szybiński Z; Huszno B; Ptak M
Przegl Lek; 2003; 60(11):768-71. PubMed ID: 15058054
[TBL] [Abstract][Full Text] [Related]
19. Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).
Lee EJ; Kim KR; Lim SK; Lee HC; Kim DI; Kim SH; Huh KB
Eur J Endocrinol; 1994 Jul; 131(1):109-12. PubMed ID: 8038902
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin-secreting pituitary adenomas: report of seven cases.
Beckers A; Abs R; Mahler C; Vandalem JL; Pirens G; Hennen G; Stevenaert A
J Clin Endocrinol Metab; 1991 Feb; 72(2):477-83. PubMed ID: 1704011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
